Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,782.81
(
2.51%
)
US TECH 100
24,184.00
(
2.72%
)
Dow Jones
47,909.92
(
2.85%
)
Brent Oil
94.84
(
-6.30%
)
Bitcoin
71,264.03
(
-1.00%
)
News Focus
News Focus

Replies to post #3442 on Biotech Values

Replies to #3442 on Biotech Values
icon url

rkrw

08/30/04 6:52 PM

#3444 RE: DewDiligence #3442

<<Absolutely correct; that’s an area badly in need of reform:>>

Dew, you're a lot tougher than I would be!
icon url

Biopharm investor

08/31/04 8:05 AM

#3449 RE: DewDiligence #3442

Loopholes

I don't agree that the FTF status is a "loophole".

I think a bigger issue is the parking of exclusivity that comes with FTF status. This prevents the opening of a market for a given drug, costing consumers millions.